What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search Research groups Stem cells and cancer The group’s strategic working lines are describing the key molecular mechanisms responsible for the self regeneration of stem cells in colon cancer (CoCSC); identifying the main molecules responsible for metastasis development in colon cancer. As well as determining the importance of new transcri Research groups Breast cancer Among the group’s current objectives is putting into practice tumour sequencing in patients with breast cancer. We are studying the efficacy of PI3K/mTOR inhibitors and their relationship with mutational state, as well as continuing research on the factors involved in resistance to HER2 treatment Research groups Early clinical development of drugs The Early Clinical Development of Drugs group promotes the early development of medicines and translational research through assessment and treatment of patients in phase I trials. They work on preliminary trials for targeted treatments aimed at cell signalling and cancer stem cells. They are als Research groups Gynaecological neoplasia The work of the Gynaecological Neoplasia research group contributes to the early clinical development of drugs against gynaecological cancers, while also seeking to consolidate a translational research programme to advance precision medicine. Research groups Thoracic tumours The group is currently focusing on putting into practice ALK translocation, studying how effective PI3K/mTOR inhibitors are in patients with EGFR-TKI-resistant lung cancer, and studying how effective PARP inhibitors are in lung cancer. They are analysing the epidemiological and clinical ch Research groups Genitourinary tumours of the CNS and sarcoma Currently, the group is focusing on designing and developing clinical trials for malignant genitourinary tumours with the active participation of researchers in the Urology, Radiotherapy and Medical Oncology departments. They are advancing in their research with the help of platforms creat Research groups Oncology data science The group’s current projects centre around the ease of molecular-clinical correlative studies in the Vall d'Hebron Institute of Oncology. It provides orientation for oncology doctors and cancer biologists during the development, validation and interpretation of "omics" tests with direct clinical Research groups Radiation oncology The group is continuing the modulated radiotherapy (MRT) programme in paediatric, gynaecological and gastrointestinal tumours. It is currently developing an extracranial stereotactic radiation therapy programme for pancreatic and lung cancer, and lung, liver and bone metastasis. At the sam Research groups Gastrointestinal and endocrine tumours The group aims to discover and validate new biomarkers, as well as develop clinical models that are relevant in vitro and in vivo, emphasising the identification of predictive markers, with the ultimate goal of improving the diagnosis and prognosis of these types of cancer. Research groups Proteomics Among the group’s current objectives is the analysis of the role of ADAM and ADAMTS metalloproteinases in tumour progression, and the detection of new cell surface markers in glioblastoma-initiating cells. The implementation of new methodologies for quantitative proteomic analyses, such as iTRAQ Pagination Previous page ‹‹ Page 67 Next page ››